Article
Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy.
Antiviral therapy - 1 Jan 2011
McKinnon John E, Delgado Rafael, Pulido Federico, Shao Wei, Arribas Jose R, Mellors John W
Abstract excerpt
BACKGROUND: Ritonavir-boosted lopinavir (LPV/RTV) alone has been evaluated as simplified maintenance therapy for HIV-1 infection, but there are concerns about greater potential for emergence of protease inhibitor (PI) resistance. The OK04 trial evaluated maintenance therapy with LPV/RTV alone versus standard therapy (ST) with two NRTIs plus LPV/RTV in 205 patients, of whom 15 had virological rebound by week 48...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
